Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjectsSTONE, Nimalie D; DUNAWAY, Shelia B; PARK, Jeong-Gun et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2351-2358, issn 0066-4804, 8 p.Article

Pharmacology of AMD3465: A small molecule antagonist of the chemokine receptor CXCR4BODART, Veronique; ANASTASSOV, Virginia; PATEL, Ketan et al.Biochemical pharmacology. 2009, Vol 78, Num 8, pp 993-1000, issn 0006-2952, 8 p.Article

Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy VolunteersNYUNT, Myaing M; BECKER, Stephen; MACFARLAND, Ron T et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 5, pp 559-565, issn 1525-4135, 7 p.Article